Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongfeng He

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Medicine|May 19, 2026
Prediction of postoperative mortality risk in hepatocellular carcinoma based on biomarkers and neural network modelsYingchen Li, Linan Yin, Bowen Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 10, 2015
Analyzing large-scale samples highlights significant association between rs10411210 polymorphism and colorectal cancerDongfeng He, Lihong Ma, Rennan Feng, et al.
BMC Medical Genomics|February 26, 2025
Targeting RECQL4 in hepatocellular carcinoma: from prognosis to therapeutic potentialYingchen Li, Linan Yin, Bowen Liu, et al.
Journal of Translational Medicine|July 18, 2015
A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancerMeng Zhou, Maoni Guo, Dongfeng He, et al.
Oncology Letters|February 9, 2026
Erratum: [Corrigendum] Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosisXunbo Hou, Qiannan Xu, Linan Yin, et al.
Oncology Letters|June 5, 2025
Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosisXunbo Hou, Qiannan Xu, Linan Yin, et al.
Sensors (Basel, Switzerland)|December 10, 2020
Low-Temperature Properties of the Magnetic Sensor with Amorphous WireDongfeng He, Kensei Umemori, Ryuichi Ueki, et al.
Molecular Biology Reports|December 17, 2016
Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON studyFengyong Liu, Zhiqiang Meng, Guoliang Shao, et al.
Frontiers in Physiology|July 26, 2021
Comparative Genomics Provide Insights Into Function and Evolution of Odorant Binding Proteins in <i>Cydia pomonella</i>Cong Huang, Xue Zhang, Dongfeng He, et al.
Translational Cancer Research|May 25, 2026
Clinical outcomes and prognostic factors of systemic therapy combined with interventional treatment in hepatocellular carcinoma: a multicenter retrospective case seriesShilong Yu, Tongguo Si, Chu Wang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Medicine|May 19, 2026
Prediction of postoperative mortality risk in hepatocellular carcinoma based on biomarkers and neural network modelsYingchen Li, Linan Yin, Bowen Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 10, 2015
Analyzing large-scale samples highlights significant association between rs10411210 polymorphism and colorectal cancerDongfeng He, Lihong Ma, Rennan Feng, et al.
BMC Medical Genomics|February 26, 2025
Targeting RECQL4 in hepatocellular carcinoma: from prognosis to therapeutic potentialYingchen Li, Linan Yin, Bowen Liu, et al.
Journal of Translational Medicine|July 18, 2015
A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancerMeng Zhou, Maoni Guo, Dongfeng He, et al.
Oncology Letters|February 9, 2026
Erratum: [Corrigendum] Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosisXunbo Hou, Qiannan Xu, Linan Yin, et al.
Oncology Letters|June 5, 2025
Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosisXunbo Hou, Qiannan Xu, Linan Yin, et al.
Sensors (Basel, Switzerland)|December 10, 2020
Low-Temperature Properties of the Magnetic Sensor with Amorphous WireDongfeng He, Kensei Umemori, Ryuichi Ueki, et al.
Molecular Biology Reports|December 17, 2016
Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON studyFengyong Liu, Zhiqiang Meng, Guoliang Shao, et al.
Frontiers in Physiology|July 26, 2021
Comparative Genomics Provide Insights Into Function and Evolution of Odorant Binding Proteins in <i>Cydia pomonella</i>Cong Huang, Xue Zhang, Dongfeng He, et al.
Translational Cancer Research|May 25, 2026
Clinical outcomes and prognostic factors of systemic therapy combined with interventional treatment in hepatocellular carcinoma: a multicenter retrospective case seriesShilong Yu, Tongguo Si, Chu Wang, et al.
Pageof 3